Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-08

Clinical Trial Update: Guanfacine to Improve Substance Use Outcomes in Women [Phase 2]

View source ↗

Summary

Phase 2 trial investigating guanfacine to improve substance use outcomes in women has completed; results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guanfacine (guanfacine)

Snippet

Sponsor: Yale University | Conditions: Substance Use Disorders | Phase 2 | Status: COMPLETED | Results posted: 2024-01-08